FDA approves GSK’s Lamictal®XR™ (lamotrigine)
27 April 2011 | By GlaxoSmithKline
The FDA has approved Lamictal® XR™ (lamotrigine) Extended-Release Tablets for conversion to monotherapy...
List view / Grid view
News
Non-Hodgkin’s Lymphoma drug market set to double to $8.4 billion by 2019
27 April 2011 | By Decision Resources
Decision Resources suggests that growth will be driven by the launches of premium-priced therapies...
Daiichi Sankyo receives first market approval in Japan for LIXIANA®
26 April 2011 | By Daiichi Sankyo
LIXIANA® (Edoxaban) is a direct oral factor Xa inhibitor for the prevention of venous thromboembolism...
DiscoveRx announces a series of scientific outreach programmes
26 April 2011 | By
To promote leading edge cell-based and biochemical GPCR and Kinase assays to the European community...
Pfizer comments on ORAL Sync tofacitinib data
25 April 2011 | By Pfizer Inc.
Pfizer has commented on an abstract concerning the ORAL Sync Phase 3 study of tofacitinib in patients with rheumatoid arthritis...
Idera Pharmaceuticals delays initiation of Phase 2 clinical trial of IMO-2125 in treatment-naïve HCV patients
22 April 2011 | By Idera Pharmaceuticals, Inc.
Delay is based on preliminary data from a 26-week nonclinical toxicology study...
Sanofi Pasteur announces FDA approval of Menactra®
22 April 2011 | By Sanofi Pasteur
Sanofi Pasteur announces that the FDA has granted licensure to expand the indication for its meningococcal conjugate vaccine...
Merck and Sanofi Pasteur initiate Phase III study in the US of pediatric combination vaccine
21 April 2011 | By Merck
Combination vaccine designed to help protect against 6 diseases: diphtheria, tetanus, whooping cough, polio, Haemophilus influenzae type b, and hepatitis B...
Researchers identify genes causing antimalarial drug resistance
21 April 2011 | By Harvard School of Public Health (HSPH)
Researchers have identified several genes that may be implicated in the malaria parasite's ability to rapidly evade drug treatments...
Molecular Profiles’ innovative drug development services win Queen’s Award for Enterprise 2011
21 April 2011 | By The Scott Partnership
Molecular Profiles awarded Queen's Award for its nanoPASST service platform...
Pfizer and Shanghai Pharmaceutical sign memorandum of understanding for potential strategic partnership
20 April 2011 | By Pfizer
Shanghai Pharmaceutical Co. Ltd. and Pfizer Inc. today announced the signing of a MOU...
Gilead and MicroDose Therapeutx announce license and collaboration agreement to develop MDT-637
20 April 2011 | By Gilead Sciences
Gilead & MicroDose Therapeutx have entered into an exclusive worldwide license...
FDA approves Roche’s HPV test for identifying women at highest risk for cervical cancer
20 April 2011 | By Roche
Roche announced that the FDA has approved the cobas HPV (Human Papillomavirus) Test...
Miles D. White elected to the American Academy of Arts & Sciences
19 April 2011 | By Abbott
Abbott announced that Miles D. White has been elected to the American Academy of Arts and Sciences...
FDA approves Rituxan plus a steroid for use in severe forms of vasculitis
19 April 2011 | By Biogen Idec
Genentech, and Biogen Idec announced today that the FDA approved Rituxan® (rituximab)...
